000 | 01735 a2200517 4500 | ||
---|---|---|---|
005 | 20250513203834.0 | ||
264 | 0 | _c20000315 | |
008 | 200003s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1002/hep.510310314 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNagler, A | |
245 | 0 | 0 |
_aOral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cMar 2000 |
||
300 |
_a641-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAutoimmunity |
650 | 0 | 4 | _aCell Transplantation |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aCollagen _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft vs Host Disease _xblood |
650 | 0 | 4 | _aIn Situ Hybridization |
650 | 0 | 4 |
_aInterferon-gamma _xblood |
650 | 0 | 4 |
_aInterleukin-10 _xblood |
650 | 0 | 4 |
_aInterleukin-2 _xblood |
650 | 0 | 4 |
_aLiver Diseases _xcomplications |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aProteins _xadministration & dosage |
650 | 0 | 4 |
_aSpleen _xcytology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
700 | 1 | _aPines, M | |
700 | 1 | _aAbadi, U | |
700 | 1 | _aPappo, O | |
700 | 1 | _aZeira, M | |
700 | 1 | _aRabbani, E | |
700 | 1 | _aEngelhardt, D | |
700 | 1 | _aOhana, M | |
700 | 1 | _aChowdhury, N R | |
700 | 1 | _aChowdhury, J R | |
700 | 1 | _aIlan, Y | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 31 _gno. 3 _gp. 641-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.510310314 _zAvailable from publisher's website |
999 |
_c10660588 _d10660588 |